Establishment Labs Holdings Inc. (ESTA)
- Previous Close
48.54 - Open
49.03 - Bid 48.43 x 200
- Ask 48.81 x 200
- Day's Range
47.90 - 49.28 - 52 Week Range
16.96 - 73.00 - Volume
92,527 - Avg. Volume
392,141 - Market Cap (intraday)
1.336B - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-3.07 - Earnings Date May 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
60.33
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
www.establishmentlabs.comRecent News: ESTA
Performance Overview: ESTA
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ESTA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ESTA
Valuation Measures
Market Cap
1.33B
Enterprise Value
1.49B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.52
Price/Book (mrq)
72.46
Enterprise Value/Revenue
8.99
Enterprise Value/EBITDA
-25.47
Financial Highlights
Profitability and Income Statement
Profit Margin
-47.53%
Return on Assets (ttm)
-16.94%
Return on Equity (ttm)
-1,537.75%
Revenue (ttm)
165.15M
Net Income Avi to Common (ttm)
-78.5M
Diluted EPS (ttm)
-3.07
Balance Sheet and Cash Flow
Total Cash (mrq)
40.03M
Total Debt/Equity (mrq)
1,044.98%
Levered Free Cash Flow (ttm)
-75.5M